Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP
- Posted on October 8, 2026
- By The Hindu
- 0 Views
- 1 min read
In brief
Generating AI summary…
Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP
India caps trade margins on non-scheduled anti-cancer drugs at 30% of MRP, aiming to cut patient costs and save ₹2,500 crore annually.
